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Background. To date, atrial fibrillation (AF) literature mostly refers to patients without concomitant 
valvular heart diseases, which are instead a relevant cohort. Aim of the study was to shed light into the 
hemodynamic impact of mitral and aortic valve diseases during AF by a computational modelling approach.  
Methods. The cardiovascular model here used has been validated over more than thirty clinical data 
regarding AF and relies on a lumped parameterization of the four heart chambers, together with the systemic 
and pulmonary circulation. Cardiac and circulatory regions are described through electric components, such 
as compliances, resistances and inductances, in terms of pressure P [mmHg], volume V [ml], flow rate Q 
[ml/s], and valve opening angle ϑ [°]. The fibrillated beating is simulated paying particular attention to the 
stochastic modeling of the irregular heartbeats, and to the missing contractility function of the atria. 
Regarding the valve dynamics, three different grades of severity (mild, moderate, severe) are simulated for 
each of the four valvulopathies (AS: aortic stenosis, MS: mitral stenosis, AR: aortic regurgitation, MR: 
mitral regurgitation), by varying - through the valve opening angle - the valve area, according to thresholds 
recommended in current valve diseases guidelines.  The computational approach allowed long time series 
(e.g. 5000 cardiac cycles), thereby yielding statistically significant results. 
Results. With respect to lone AF simulation values, mean pulmonary vein pressure (Ppvn) increased by 
31.4%, 27.7%, and 23.2%, in case of severe MR, AR, and MS, respectively. Similarly mean left atrial 
pressure (Pla), increased by 34.4%, 30.7% and 25.2% in case of severe MR, AR and MS. Mean left 
ventricular volume (Vlv) increased due to severe AR (+28.8%) and MR (+7.4%), and decreased in case of 
severe MS (-18.7%). Stroke volume (SV) showed an upsurge in severe AR (+102.7%) and MR (+88.0%), 
and a decrease in severe MS (-12.9%). Mean systemic pressure (Psas) declined in severe AR (-24.1%), MR (-
22.8%) and MS (-12.4%), with a concomitant decrease of cardiac output (CO) in the severe MR (-22.5%), 
AR (-20.5%) and MS (-13.8%) simulations. Concerning grading of valve diseases, regurgitations already 
have strong hemodynamic impact when mild, while MS displays a progressively greater influence as the 
grading increases. 
Conclusions. Regurgitations presented the strongest impact on hemodynamics, immediately followed by 
MS; conversely, AS was the less-impacting between the studied valvular diseases. These findings, if 
clinically confirmed, hold the potential to impact AF management (e.g. adoption of a rhythm control 
strategy) in case of a specific valvular disease.  
 
